Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

327

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

November 30, 2017

Study Completion Date

August 7, 2018

Conditions
Metastatic gpNMB Over-expressing Triple Negative Breast Cancer
Interventions
DRUG

CDX-011

DRUG

Capecitabine

Trial Locations (140)

1000

Institute Jules Bordet, Brussels

1180

Clinique Edith Cavell, Brussels Capital Region

2010

St. Vincents Hospital Sydney, Darlinghurst

2076

Sydney Adventist Hospital, Wahroonga

2109

Macquarie University, Macquarie Park

2485

The Tweed Hospital, Tweed Heads

2610

GasthuisZusters Antwerpen, Wilrijk

3000

UZ Leuven, Leuven

3011

Western Hospital, Footscray

3084

Joint Ludwig-Austin Dept of Medical Oncology, Heidelberg

3121

Epworth Health Care, Richmond

3128

Box Hill Hospital, Box Hill

4814

Townsville Hospital, Douglas

6000

Grand Hopital de Charleroi asbl, Charleroi

10011

Beth Isreal Medical Center, New York

10021

Weill Cornell Medical Center, New York

10126

Azienda Ospedaliera Citta della Salute e della Scienza de Torino, Torino

11042

Clinical Research Alliance, Inc., Lake Success

ProHEALTH Care Associates, Lake Success

11794

Stony Brook University Medical Center, Stony Brook

12002

Consorcio Hospitalario Provincial de Castellon, Castellon

13125

Helios Klinikum Berlin Buch, Berlin

18840

Guthrie Clinical Research, Sayre

19047

St Mary Medical Center, Langhorne

19111

Fox Chase Cancer Center, Philadelphia

20089

Istituto Clinico Humanitas, Rozzano

20121

Azienda Ospedaliera Fatebenefratelli e Oftaimico, Milan

20133

Istituto Nazionale Dei Tumori, Milan

20141

Istituto Europeo Di Oncologia, Milan

20902

Holy Cross Hospital, Silver Spring

21201

University of Maryland, Baltimore

21401

Anne Arundel Medical Center, Annapolis

21701

Frederick Memorial Hospital, Frederick

27710

Duke University Medical Center, Durham

28033

MD Anderson Cancer Center Madrid-Espana, Madrid

28034

Hospital Universitario Ramon y Cajal, Madrid

28204

Novant Health, Charlotte

29011

Hospital Regional Universitario de Malaga - Hospital General, Málaga

29414

Charleston Hematology Oncology Associates (CHOA), Charleston

30060

Northwest Georgia Oncology Centers P.C., Marietta

30318

Peachtree Hematology Oncology Consultants, PC, Atlanta

30322

Winship Cancer Institute, Emory University, Atlanta

30341

Georgia Cancer Specialists Clinic, Atlanta

31405

Summit Cancer Care, PC-Savannah, Savannah

32207

Baptist Cancer Institute, Jacksonville

32308

Tallahassee Memorial HealthCare, Tallahassee

33011

Hospital Universitario Central de Asturias, Oviedo

33021

Memorial Regional Hospital, Hollywood

33081

Centro Di Riferimento Oncologico, Aviano

33442

University of Miami Miller School of Medicine, Deerfield Beach

33916

Florida Cancer Specialists South, Fort Myers

34655

Florida Cancer Specialists, New Port Richey

35211

Alabama Oncology, Birmingham

35294

University of Alabama at Birmingham, Birmingham

35768

Centre Hospitalier Prive Saint-Gregoire, Saint-Grégoire

36604

University of South Alabama Cancer Research Insititute, Mobile

37203

Sarah Cannon Cancer Center, Nashville

37404

Chattanooga Oncology Hematology Associates, Chattanooga

37909

Center for Biomedical Research, LLC, Knoxville

40000

Centre Hospitalier de Mont de Marson - Hôpital Layné, Mont-de-Marsan

40138

Azienda Ospedaliero Universitaria Di Bologna - Policlinico S Orsola Malpighi, Bologna

40225

Universitätsklinikum Düsseldorf, Düsseldorf

44195

Cleveland Clinic-Taussig Cancer Institute-R35, Cleveland

45042

Signal Point Clinical Research Center, LLC, Middletown

45242

Oncology Hematology Care, Cincinnati

46010

Hospital Clinico Universitario de Valencia, Valencia

47014

Istituto Scientifico romagnolo Per Lo Studio E La Cura Del Tumori IRST, Meldola

48149

Universitätsklinikum Münster, Münster

51067

Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide, Cologne

53840

Hämatologisch-Onkologische Schwerpunktpraxis, Troisdorf

55407

Virginia Piper Cancer Center, Minneapolis

56126

Azienda Ospedaliera Universitaria Pisana, Pisa

59000

Centre Oscar Lambret, Lille

60077

Orchard Healthcare Research Inc., Skokie

60426

Ingalis Memorial Hospital, Harvey

60615

Illinois CancerCare, Peoria

60637

University of Chicago, Chicago

61801

Carle Cancer Center, Urbana

63110

Washington University Dept of Oncology, St Louis

63141

St John's Mercy Medical Center, St Louis

64132

HCA Midwest Health, Kansas City

65929

Klinikum Frankfurt Höchst GmbH, Frankfurt am Main

66421

Universität Des Saarlandes, Homberg (Efze)

69317

Hôpital de La Croix Rousse, Lyon

69373

Centre Léon Bérard Centre Régional de Lutte Contre Le Cancer Rhône Alpes, Lyon

69495

Hospices Civils de Lyon, Pierre-Bénite

70072

Hematology and Oncology Specialists, Marrero

70112

Louisiana State University Health New Orleans, New Orleans

70121

Oschner Medical Center, New Orleans

70503

Lafayette General Medical Center, Lafayette

72000

Centre Jean Bernard Clinique Victor Hugo, Le Mans

72205

University of Arkansas for Medical Sciences, Little Rock

73120

Mercy Clinic of Oklahoma, Oklahoma City

73730

Klinikum Essingen GmbH, Esslingen am Neckar

75005

Institut Curie, Paris

76104

Oncology Hematology Consultants PA, Fort Worth

77030

Baylor College of Medicine, Houston

Houston Methodist Cancer Center, Houston

University of Texas Health Science Center at Houston, Houston

79430

Texas Tech University Health Sciences Center, Lubbock

80637

Rotkreuzklinikum München, Munich

84000

Institut Sainte Catherine, Avignon

85304

Arizona Cancer Research Alliance, Glendale

85724

Arizona Cancer Center, Tucson

90033

USC Norris Comprehensive Cancer Center and Hospital, Los Angeles

91054

Universitätsklinikum Erlangen, Erlangen

91307

Wellness Hematology Oncology, West Hills

92708

Compassionate Care Research Group, Fountain Valley

92835

St. Jude Heritage Medical Group, Fullerton

93901

Pacific Cancer Care, Salinas

94115

University of California San Francisco, San Francisco

94589

Kaiser Permaente, Vallejo

95817

University of California Davis Medical Center, Sacramento

97006

Oregon Health and Science University, Beaverton

98104

Swedish Cancer Institute, Seattle

98109

Seattle Cancer Care Alliance, Seattle

21287-0013

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

08822

Hunterdon Regional Cancer Center, Flemington

07601

Hackensack University Medical Center, Hackensack

P6B-0A8

Algoma District Cancer Program Sault Area Hospital, Sault Ste. Marie

M4N 3M5

Sunnybrook Health Sciences Centre Odette Cancer Center, Toronto

M5B 1W8

St. MIchael's Hospital, Toronto

H3T 1E2

Sir Mortimer B Davis Jewish General Hospital, Montreal

H4J 1C5

Universite de Montreal-Hopital Du Sacre-Coeur De Montreal, Montreal

06189

Centre Antoine Lacassagne Centre Régional de Lutte Contre Le Cancer, Nice

06120

Martin-Luther-Universität Halle-Wittenberg, Halle

00168

Fondazione Policlinico Universitario A Gemelli, Rome

08916

Hospital Universitari Germans Trias i Pujol, Badalona

08208

Corporacio Sanitaria Parc Tauli, Sabadell

08035

Hospital Universitario Vall d'Hebron, Barcelona

08036

Hospital Clinic de Barcelona, Barcelona

Unknown

Hospital Clinico San Carlos, Madrid

EC1A 7BE

Barts Health NHS Trust, London

PL6 8DH

Derriford Hospital, Plymouth

BN2 5BE

Royal Sussex County Hospital, Brighton

G12 0YN

Beatson West of Scotland Cancer Centre, Glasgow

FY3 8NR

Blackpool Victoria Hospital, Blackpool

NW1 2PG

University College London, London

NG5 1PB

Nottingham University Hospitals NHS Trust, Nottingham

W1G 6AD

Sarah Cannon Research Institute UK, City of London

Sponsors
All Listed Sponsors
lead

Celldex Therapeutics

INDUSTRY

NCT01997333 - Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer | Biotech Hunter | Biotech Hunter